🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
1,032

Quick answer

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. rF1V-1018

    United Therapeutics Europe Ltd

    Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

    phase 2 mab active

    1 trial

  2. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 mab completed

    1 trial

  3. sublingual nitroglycerine

    United Therapeutics Europe Ltd

    COLIC

    phase 2 small molecule active

    1 trial

  4. treprostinil dienthanolmine sustained release

    United Therapeutics Europe Ltd

    Critical Limb Ischemia

    phase 2 small molecule completed

    1 trial

  5. treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Systemic Sclerosis

    phase 2 small molecule completed

    2 trials

  6. trihexyphenidyl

    United Therapeutics Europe Ltd

    Dystonia

    phase 2 small molecule completed

    1 trial

  7. zinc supplementation

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 small molecule completed

    1 trial

  8. 18F-PEG6-IPQA

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 small molecule completed

    1 trial

  9. 3-dimensional conformal radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 1 other active

    1 trial

  10. 89Zr-DFO-YS5

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  11. ARN-75039 oral capsules

    United Therapeutics Europe Ltd

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial

  12. ASTX660

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  13. ATRA

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma

    phase 1 small molecule completed

    1 trial

  14. AZD2014 3 on/4 off & weekly paclitaxel

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  15. Acceptance and Commitment Therapy

    United Therapeutics Europe Ltd

    Stroke

    phase 1 other completed

    1 trial

  16. Administration of UI087

    United Therapeutics Europe Ltd

    Diabetes Mellitus (Type 2)

    phase 1 small molecule active

    1 trial

  17. Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)

    United Therapeutics Europe Ltd

    Urothelial Carcinoma

    phase 1 mab active

    1 trial

  18. Allogeneic (MSC's) Application to the Burn Wounds

    United Therapeutics Europe Ltd

    Skin Burn Degree Second

    phase 1 mab completed

    1 trial

  19. Allogeneic MSC

    United Therapeutics Europe Ltd

    Mesenchymal Stromal Cells

    phase 1 mab completed

    1 trial

  20. Anplag

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  21. Anti CS6 BSIgG product (Lot PD1601105CS)

    United Therapeutics Europe Ltd

    Healthy Volunteer

    phase 1 mab completed

    1 trial

  22. Antibody UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection in Adults (Asymptomatic)

    phase 1 small molecule completed

    1 trial

  23. Arm B: A combination of pentoxifylline and tocopherol acetate in addition to best standard care [a structured programme of rehabilitation exercises] for 6 months

    United Therapeutics Europe Ltd

    Head and Neck Fibrosis

    phase 1 other completed

    1 trial

  24. Atovaquone Oral Suspension

    United Therapeutics Europe Ltd

    Locally Advanced Non-Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  25. Autologous Engineered Urethral Construct

    United Therapeutics Europe Ltd

    Urologic Diseases

    phase 1 mab active

    1 trial

  26. Autologous Human Schwann Cell

    United Therapeutics Europe Ltd

    Peripheral Nerve Injury

    phase 1 mab active

    1 trial

  27. Autologous tissue engineered corpora

    United Therapeutics Europe Ltd

    Urologic Diseases

    phase 1 mab active

    1 trial

  28. BIO 300 Oral Powder

    United Therapeutics Europe Ltd

    Acute Radiation Syndrome

    phase 1 small molecule completed

    1 trial

  29. Biospecimen Collection

    United Therapeutics Europe Ltd

    Glioma

    phase 1 other active

    1 trial

  30. CABG + Mitral valve annuloplasty

    United Therapeutics Europe Ltd

    Mitral Regurgitation

    phase 1 other completed

    1 trial

  31. CCT3833

    United Therapeutics Europe Ltd

    Melanoma

    phase 1 small molecule completed

    1 trial

  32. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine

    United Therapeutics Europe Ltd

    HER2 Negative Breast Carcinoma

    phase 1 mab active

    1 trial

  33. CE marked Philips Motiva system

    United Therapeutics Europe Ltd

    COPD

    phase 1 other completed

    1 trial

  34. CHR-2797 (tosedostat)

    United Therapeutics Europe Ltd

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  35. COVID-HIG

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 1 mab completed

    1 trial

  36. COVID-HIGIV

    United Therapeutics Europe Ltd

    COVID-19

    phase 1 mab completed

    1 trial

  37. CXD101

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  38. Cabozantinib Oral Tablet

    United Therapeutics Europe Ltd

    Neurofibromatosis 1

    phase 1 small molecule active

    1 trial

  39. Cam2020 M2SR H3N2 influenza vaccine

    United Therapeutics Europe Ltd

    Influenza Vaccine

    phase 1 mab completed

    1 trial

  40. Campylobacter jejuni strain CG8421

    United Therapeutics Europe Ltd

    Campylobacter Infections

    phase 1 mab active

    1 trial

  41. Carbidopa

    United Therapeutics Europe Ltd

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  42. Chlorhexidine

    United Therapeutics Europe Ltd

    Peri-Implantitis

    phase 1 small molecule active

    1 trial

  43. Cisplatin

    United Therapeutics Europe Ltd

    Advanced Cholangiocarcinoma

    phase 1 small molecule terminated

    1 trial

  44. Clinical Center Reference Endotoxin (CCRE)

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  45. Cyclophosphamide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 small molecule active

    1 trial

  46. D/ChAd63-CA

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  47. D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

    United Therapeutics Europe Ltd

    Dengue

    phase 1 mab completed

    1 trial

  48. DFUPS

    United Therapeutics Europe Ltd

    Diabetic Foot

    phase 1 other completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.